Covered recipient · General Payments record
MARY K LAWRENCE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$163,016.12
- Reported across 706 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,249.88 | 67 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $742.50 | 1 |
| Travel and Lodging | $227.94 | 1 |
| Education | $163.49 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CeQur Corporation | $999.52 | 3 |
| Amgen Inc. | $226.48 | 9 |
| Abbott Laboratories | $138.26 | 12 |
| Astellas Pharma US Inc | $126.64 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $117.54 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $97.50 | 6 |
| Lilly USA, LLC | $64.94 | 4 |
| IDORSIA PHARMACEUTICALS US INC | $60.41 | 1 |
| Novo Nordisk AS | $49.05 | 3 |
| ABBVIE INC. | $47.58 | 4 |
| Insulet Corporation | $46.20 | 2 |
| Sumitomo Pharma America, Inc. | $44.96 | 2 |
| BETA BIONICS, INC. | $42.76 | 2 |
| Rhythm Pharmaceuticals, Inc. | $40.48 | 2 |
| PFIZER INC. | $36.30 | 2 |
| Merck Sharp & Dohme Corporation | $32.32 | 2 |
| Medtronic, Inc. | $29.42 | 2 |
| Kyowa Kirin, Inc. | $24.73 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.06 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.14 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.59 | 1 |
| Kiniksa Pharmaceuticals International, plc | $18.57 | 1 |
| Amneal Pharmaceuticals LLC | $16.42 | 1 |
| Ascendis Pharma Inc | $16.11 | 1 |
| MannKind Corporation | $15.70 | 1 |
| Almatica Pharma Inc. | $15.49 | 1 |
| iRhythm Technologies, Inc. | $14.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (72)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.